Ischemic Heart Disease
📧 Sign up to get email alerts when something new happens for Ischemic Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-06-23Clinical Trial Update: Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease
This clinical trial update examines water and salt homeostasis in healthy volunteers and patients with heart- or lung-related diseases; the …
-
FDA approval · 2011-06-22FDA Approved: THALLOUS CHLORIDE TL 201 — Supplemental Application (Curium US LLC)
FDA approved a supplemental application for Thallous chloride TL 201 from Curium US LLC, indicating an updated or expanded regulatory cleara…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA [Phase 2]
This is a Phase 2 clinical study evaluating Nesiritide in patients undergoing CABG surgery that has completed. The trial status is finished.
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease [NA]
This update reports the completion of a cluster randomized trial evaluating whether opinion leader–endorsed evidence summaries can improve q…
-
CLINICAL_TRIALS research · 2011-05-06Clinical Trial Update: Intermittent Normoxia Reduces Myocardial Reperfusion Injury [NA]
A clinical trial update from Central South University investigates whether intermittent normoxia can reduce myocardial reperfusion injury, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-04-29FDA Approved: ISOSORBIDE MONONITRATE — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
The FDA approved a supplemental application for Isosorbide Mononitrate submitted by Edenbridge Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery [Phase 3]
A Phase 3 trial evaluating N-Acetylcysteine to prevent renal injury after cardiac surgery has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-11Clinical Trial Update: The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions [NA]
The ENDEAVOR II trial update notes completion of the study assessing the Endeavor Drug-Eluting Coronary Stent System for coronary artery les…
-
CLINICAL_TRIALS trial_result · 2011-03-03Clinical Trial Update: Cardioprotective Effects of Endogenous Erythropoietin in Patients Undergoing Coronary Artery Bypass Surgery [NA]
This completed clinical trial evaluated whether endogenous erythropoietin offers cardioprotection in patients undergoing coronary artery byp…
-
FDA approval · 2011-02-25FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (PETNET Solutions, Inc.)
The FDA approved an original application for Fludeoxyglucose F-18 (FDG F-18) as a radiopharmaceutical for PET imaging, submitted by PETNET S…
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: A Clinical Evaluation of the ProNOVA XR Polymer Free Drug Eluting Coronary Stent System [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical evaluations of the ProNOVA XR polymer-free drug-eluting coronary stent system have been completed.
-
CLINICAL_TRIALS research · 2011-01-14Clinical Trial Update: MRI Perfusion Imaging at 3Tx Compared to Invasive FFR Measurements
Clinical trial update comparing MRI perfusion imaging at 3 Tesla with invasive fractional flow reserve measurements to assess myocardial isc…
-
FDA approval · 2011-01-05FDA Approved: AMMONIA N 13 — Supplemental Application (THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH)
FDA approved a supplemental application for Ammonia N 13 (NH3N13) from The Feinstein Institutes for Medical Research, updating its labeling …
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion [NA]
This clinical trial update compares everolimus-eluting stents (EES) with sirolimus-eluting stents (SES) for bifurcation lesions in ischemic …
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Effect of Heparin on Femoral Arterial Sheaths Thrombosis During Diagnostic Coronary Angiography [Phase 3]
Phase 3 trial assessing whether heparin reduces thrombus formation on femoral arterial sheaths during diagnostic coronary angiography; study…
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention [Phase 3]
Phase 3 trial evaluating whether liposomal prostaglandin E1 (Lipo-PGE1) reduces myocardial injury after percutaneous coronary intervention.
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: The Effect of Ischaemic-Reperfusion and Ischaemic Preconditioning on the Endogenous Fibrinolysis in Man [NA]
A completed clinical trial evaluating the effects of ischemia-reperfusion and ischemic preconditioning on endogenous fibrinolysis in humans.
-
CLINICAL_TRIALS research · 2010-10-25Clinical Trial Update: The Effect of Ischaemic-reperfusion on the Endogenous Fibrinolysis in Man [NA]
Clinical trial update on the effect of ischemia-reperfusion on endogenous fibrinolysis in humans; the trial related to ischemic heart diseas…
-
CLINICAL_TRIALS research · 2010-09-20Clinical Trial Update: IRB-HSR# 15084 A Prospective, Unblinded, Controlled Study to Evaluate the Effect of the ITPR in Patients Undergoing OPCAB Surgery [Phase 2]
Phase 2 prospective, unblinded, controlled study evaluating the effect of the ITPR in patients undergoing off-pump coronary artery bypass gr…
-
FDA approval · 2010-07-29FDA Approved: CARDIOGEN-82 — Supplemental Application (Bracco Diagnostics Inc)
FDA approved a supplemental application for CARDIOGEN-82 (Rubidium-82 chloride RB-82) submitted by Bracco Diagnostics Inc.
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: Pulse Pressure Variation (PPV) to Predict Fluid Responsiveness During Cardiac Displacement in Patients Undergoing Off-pump Coronary Artery Bypass Surgery (OPCAB) [NA]
A completed clinical trial evaluated whether pulse pressure variation can predict fluid responsiveness during cardiac displacement in patien…
-
FDA approval · 2010-07-12FDA Approved: NITROSTAT — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Nitrostat (nitroglycerin) submitted by Viatris Specialty LLC, resulting in an updated labeli…
-
CLINICAL_TRIALS trial_result · 2010-06-15Clinical Trial Update: Passive Leg Raising Test to Predict Hypotension During Induction of Anesthesia in Patients Undergoing Cardiac Surgery [Phase 2]
A Phase 2 clinical trial assessing whether a passive leg raising test can predict hypotension during induction of anesthesia in patients und…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery [Phase 2]
Phase 2 trial comparing AQUAVAN Injection to DISOPRIVAN Injectable Emulsion for anesthesia during coronary artery bypass surgery has complet…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Treatment of Bifurcation Lesions by SINGLE STENT and KISSing Balloon Trial [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating treatment of bifurcation lesions using a SINGLE STENT and KI…